CVRx (CVRX) EBIT Margin Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -430.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 128.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -361.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 102.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 241.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 851.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -313.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 535.00 |
| 10 | CVRx | 144.43 Mn | 72.13 Mn | 12.88 Mn | 2,648.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,648.00 |
| Dec 31, 2025 | -5,854.00 |
| Sep 30, 2025 | 1,378.00 |
| Jun 30, 2025 | 1,255.00 |
| Mar 31, 2025 | 9,761.00 |
| Dec 31, 2024 | 32,425.00 |
| Sep 30, 2024 | -665.00 |
| Jun 30, 2024 | 536.00 |
| Mar 31, 2024 | -5,400.00 |
| Dec 31, 2023 | 7,451.00 |
| Sep 30, 2023 | 7,304.00 |
| Jun 30, 2023 | 9,522.00 |
| Mar 31, 2023 | 9,066.00 |
| Dec 31, 2022 | 8,028.00 |
| Sep 30, 2022 | 5,106.00 |
| Jun 30, 2022 | -3,730.00 |
| Mar 31, 2022 | -9,563.00 |
| Dec 31, 2021 | -13,799.00 |
| Sep 30, 2021 | 9,036.00 |
| Jun 30, 2021 | 6,318.00 |